FA
Forefront Analytics Portfolio holdings
AUM
$89.5M
This Quarter Return
+0.63%
1 Year Return
+11.48%
3 Year Return
+24.94%
5 Year Return
+31.9%
10 Year Return
–
AUM
$209M
AUM Growth
+$209M
(+1.3%)
Cap. Flow
+$4.01M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
54.48%
Holding
72
New
5
Increased
39
Reduced
22
Closed
4
Top Buys
| 1 |
Nuveen ESG Large-Cap Value ETF
NULV
|
$10.9M |
| 2 |
NVIDIA
NVDA
|
$3.63M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.23M |
| 4 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
$1.23M |
| 5 |
JPMorgan Chase
JPM
|
$662K |
Top Sells
| 1 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
$16.6M |
| 2 |
FlexShares STOXX Global ESG Select Index Fund
ESGG
|
$810K |
| 3 |
Invesco Dorsey Wright Momentum ETF
PDP
|
$266K |
| 4 |
Vanguard Value ETF
VTV
|
$263K |
| 5 |
Medtronic
MDT
|
$257K |
Sector Composition
| 1 | Technology | 1.84% |
| 2 | Healthcare | 1.53% |
| 3 | Financials | 0.63% |
| 4 | Industrials | 0.4% |
| 5 | Consumer Staples | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
| $361K | 0.17% |
+7,232
| New | +$361K |
|
52
Regeneron Pharmaceuticals
REGN
$61.5B
| $345K | 0.17% |
328
-16
| -5% | -$16.8K |
|
53
RPAR Risk Parity ETF
RPAR
$523M
| $313K | 0.15% |
16,399
-2,667
| -14% | -$51K |
|
54
iShares Global REIT ETF
REET
$4B
| $305K | 0.15% |
13,137
-2,117
| -14% | -$49.2K |
|
55
Philip Morris
PM
$260B
| $278K | 0.13% |
+2,738
| New | +$278K |
|
56
Thermo Fisher Scientific
TMO
$186B
| $253K | 0.12% |
456
-50
| -10% | -$27.8K |
|
|
KRON
57
DELISTED
Kronos Bio
KRON
| $167K | 0.08% |
134,998
+57,867
| +75% | +$71.8K |
|
58
Zura Bio
ZURA
$133M
| $145K | 0.07% |
41,569
+7,531
| +22% | +$26.4K |
|
59
Immatics
IMTX
$619M
| $139K | 0.07% |
+11,987
| New | +$139K |
|
60
Cogent Biosciences
COGT
$1.69B
| $132K | 0.06% |
15,627
-3,648
| -19% | -$30.8K |
|
|
MREO
61
Mereo BioPharma
MREO
$272M
| $130K | 0.06% |
36,231
-7,586
| -17% | -$27.3K |
|
62
Athira Pharma
ATHA
$15.3M
| $123K | 0.06% |
46,595
+25,979
| +126% | +$68.8K |
|
63
Travere Therapeutics
TVTX
$1.56B
| $109K | 0.05% |
13,317
+1,237
| +10% | +$10.2K |
|
|
PSTX
64
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $87.1K | 0.04% |
29,817
+3,037
| +11% | +$8.87K |
|
65
Geron
GERN
$893M
| $84.4K | 0.04% |
19,906
+2,030
| +11% | +$8.61K |
|
66
Annexon
ANNX
$226M
| $78.9K | 0.04% |
16,103
+1,285
| +9% | +$6.3K |
|
67
CytomX Therapeutics
CTMX
$336M
| $78.2K | 0.04% |
64,065
+43,176
| +207% | +$52.7K |
|
68
Nkarta
NKTX
$151M
| $69.9K | 0.03% |
+11,833
| New | +$69.9K |
|
69
ALX Oncology
ALXO
$62.7M
| – | – |
-10,261
| Closed | -$114K |
|
|
70
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.89B
| – | – |
-207,750
| Closed | -$16.6M |
|
|
71
Medtronic
MDT
$119B
| – | – |
-2,952
| Closed | -$257K |
|
|
ACHL
72
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| – | – |
-95,445
| Closed | -$119K |
|